Skip to content
healthcare.dev

Glipizide

NDC 71610-175, Glipizide, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-175
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075795
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
71610-175-457161001754545 TABLET in 1 BOTTLE (71610-175-45)
71610-175-607161001756090 TABLET in 1 BOTTLE (71610-175-60)
71610-175-8071610017580180 TABLET in 1 BOTTLE (71610-175-80)
71610-175-9271610017592270 TABLET in 1 BOTTLE (71610-175-92)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f620559f-985b-421f-98df-bc2ca1cb0ece

Use it

Look up 71610-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.